期刊文献+

数据挖掘在疫苗风险监测中的应用研究 被引量:3

Research of Data Mining in Monitoring Risk of Vaccines
下载PDF
导出
摘要 目的探索适合我国的疫苗不良事件数据挖掘方法。方法检索各种数据挖掘有关文献,对其进行研究、分析和比较。结果目前各国普遍使用的信号检测方法主要有频数法和贝叶斯法,前者主要有比例报告比法、报告比值比法、MHRA法等;后者包括贝叶斯判别可信区间递进神经网络模型与相对比值法等。结论在疫苗风险监测中应用信号检测方法是可行性,建议综合采用BCPNN、PRR、ROR、MHRA等多种方法。 Objective To probe into data mining methods for vaccines adverse event in China.Methods Literatures concerning data mining methods were reviewed for further analysis and comparison.Results Frequency method and Bayesian method were the two main data mining algorithms used in pharmacovigilance in various countries nowadays.The former includes proportional reporting ratio(PRR),reporting odds ratio(ROR) and MHRA and the latter includes Bayesian Confidence Propagation Neural Network(BCPNN) and relative rate(RR).Conclusion Data mining in monitoring risk of vaccines is feasible.It is suggested that BCPNN,PRR,ROR and MHRA are integratedly used in the signal detection.
出处 《中国药事》 CAS 2011年第5期434-437,共4页 Chinese Pharmaceutical Affairs
基金 科技部课题资金资助项目(编号2009ZX10004-806)
关键词 疫苗 信号 风险 数据挖掘 vaccine signal risk data mining
  • 相关文献

参考文献16

二级参考文献59

共引文献82

同被引文献43

  • 1孙昱.突发公共卫生事件相关的药品审评审批政策思考[J].药物评价研究,2020,0(3):402-411. 被引量:8
  • 2蔡伟,纪冬霞,赵贤.药物警戒与药物不良反应监测辨析及其意义[J].国际医药卫生导报,2006,12(20):48-50. 被引量:15
  • 3Waldman EA, Luhm KR, Monteiro SA, et al. Surveillance of adverse effects following vaccination and safety of immunization programs[J]. Revista de saude publica, 2011, 45 (1) : 173-84.
  • 4World Health Organization. Global manual on surveillance of adverse events following immunization [EB/OL]. (2014- 09) [2015-05-10]. http: //www.who.int/vaccine_safety/ puhlications/en/.
  • 5Bonhoeffer J, Black S, Izurieta H, et al. Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe[J]. Biologicals, 2012, 40 (5) : 393-397.
  • 6Huang YL, Moon J, Segal JB. A comparison of active adverse event surveillance systems worldwide[J]. Drug Saf, 2014, 37 (8) : 581-596.
  • 7World Health Organization. Global vaccine safety blueprint [EB/OL]. (2012-02) [2015-05-10]. http: //www.who.int/ vaccine_safety/en/.
  • 8European Medicines Agency. Guideline on good pharmacovigilance practices: Module VIII-Post-authorisation safety studies [EB/OL]. ( 2013-04-19 ) [2015-05-10]. http : //www.ema.europa.eu/ema/index jsp?curl=pages/regulation/document_listing/document_ listing 000377.jsp&mid=WC0bO 1 acO58066e979.
  • 9ICH : Pharmacovigilance planning [EB/OL]. (2004-12-01) [2015-05-10]. http: //www.ich.org/products/guidelines/ efficacy/efficacy-single/article/pharmacovigilance- planning.html.
  • 10US CDC: Vaccine safety [EB/OL]. (2014-10-10) [2015- 05-10]. http: //www.cdc.gov/vaccinesafety/Activities/vsd. html.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部